University of California Launching Future Leaders in Global Health Research Training Program

加州大学推出全球健康研究未来领导者培训计划

基本信息

  • 批准号:
    10881124
  • 负责人:
  • 金额:
    $ 16.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-04 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

In response to RFA-TW-21-004, the University of California Global Health Institute (UCGHI), including UC San Francisco (UCSF), UC San Diego (UCSD), UC Los Angeles (UCLA) and UC Davis (UCD), along with a network of 21 collaborating institutions in low- to middle-income countries (LMICs), proposes to continue our successful GloCal Health Fellowship (GloCal). Our LMIC sites are well-established, work in regions with some of the highest burden of disease, and stand to benefit from our program’s capacity building, mentorship training and alumni support. GloCal is the only UC-wide global health training program, and our track record shows that we: 1) Recruit pre- and postdoctoral trainees diverse in discipline and race [39% of U.S. trainees over the past 5 years identify as an underrepresented minority (URM)] who aspire to build interdisciplinary academic research careers in global health; 2) Provide outstanding, interdisciplinary education and training in global health in collaboration with faculty mentors from participating UC campuses and collaborating LMIC institutions; and 3) Provide each trainee with a rich and enduring mentored research experience that fosters scientific and career development in global health. The program also advances long-term objectives to 1) Develop models of interdisciplinary, innovative global health research and training designed to ensure healthy lives and promote well-being for all; 2) Enhance global health networks between the UC and our LMIC partners and recruit faculty leading innovative global health research; and 3) Strengthen a sustainable and equitable model of collaboration between the UC and our LMIC partners that develops research capacity that advances locally-led and locally-relevant research. GloCal will recruit candidates from a pipeline of 65 T32 and 13 D43 programs. GloCal trainees are at different career stages, but all receive: 1) A 9 or 12-month, hands-on research experience onsite with one of our LMIC partners—LMIC fellows will spend their first 2 to 3 months of the program at UC and earn a certificate in ‘conducting global health research’; 2) A strong, interdisciplinary mentored research experience; 3) Instruction in global health through onsite and online courses; and 4) Career development to ensure that they attain their short-term goals and succeed in transitioning to the next career stage. GloCal leadership and standing committees ensure that these program components form a seamless, integrated experience supported by evaluation and continuous improvement. Strengths and innovations of the program include: 1) A unified consortium under UCGHI that includes four UCs at the leading edge of global health 2) Recruitment of diverse U.S. trainees across UC and the UCLA-Charles Drew University partnership; 3) Mentors offering training across diverse disciplines (e.g., medicine, nursing, dentistry, public health, veterinary science, environmental and social sciences) and in research methods; and 4) Leveraging common resources across the four participating UC campuses (UCGHI, CTSAs and CFARs). UCGHI is committed to supporting the success of GloCal, as evidenced by their pledge of $600,000 in co-funding.
为了回应RFA-TW-21-004,加利福尼亚大学全球健康研究所(UCGHI),包括UC SAN Francisco(UCSF),UC圣地亚哥(UCSD),UC洛杉矶(UCLA)和UC Davis(UCD),以及 低至中等收入国家(LMIC)的21个合作机构的网络,提案继续我们 成功的全球健康研究金(Glocal)。我们的LMIC网站已经建立了良好的地方,在某些地区工作 疾病负担最高,并从我们计划的能力建设,Mentalship Training中受益 和校友支持。 GlobalCal是唯一的全球全球健康培训计划,我们的往绩记录表明 我们:1)招募纪律和种族的博士后和博士后学员[过去39%的美国实习生 渴望建立跨学科学术的5年确定为人数不足的少数族裔(URM) 全球健康研究职业; 2)在全球提供出色的跨学科教育和培训 健康与参与UC校园的教师导师合作并合作LMIC 机构; 3)为每个受训者提供丰富而持久的研究经验 全球健康方面的科学和职业发展。该计划还将长期目标提高到1) 开发跨学科,创新的全球健康研究和培训旨在确保健康的模型 为所有人生活和促进幸福; 2)增强UC与我们的LMIC合作伙伴之间的全球健康网络 并招募教师领先的创新全球健康研究; 3)加强可持续和公平的 UC与我们的LMIC合作伙伴之间的合作模型,该合作伙伴发展了发展的研究能力 本地领导和与当地的研究。 Glocal将从65 T32和13 D43的管道中招募候选人 程序。全球学员处于不同的职业阶段,但所有人都接受:1)9或12个月的动手 与我们的LMIC合作伙伴之一的现场研究经验 - LMIC研究员将花费前2至3个月 UC的计划并获得“进行全球卫生研究”的证书; 2)强大的跨学科 指导的研究经验; 3)通过现场和在线课程指导全球健康的指导; 4)职业 开发以确保他们实现自己的短期目标并成功过渡到下一个职业 阶段。全球领导和常务委员会确保这些计划组件形成无缝, 评估和持续改进支持的综合经验。优势和创新 程序包括:1)UCGHI下的一个统一财团,其中包括全球领先优势的四个UCS 健康2)在UC和UCLA-Charles Drew University Partnership中招募美国学员的潜水员; 3)提供跨潜水学科培训的导师(例如,医学,护士,牙科,公共卫生, 兽医科学,环境和社会科学)以及研究方法; 4)利用普通 四个参与UC校园(UCGHI,CTSA和CFARS)的资源。 UCGHI致力于 支持Glocal的成功,这证明了他们的共同资金60万美元的承诺。

项目成果

期刊论文数量(203)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
DNA methylation patterns associated with konzo in Sub-Saharan Africa.
  • DOI:
    10.1186/s13148-022-01372-x
  • 发表时间:
    2022-12-19
  • 期刊:
  • 影响因子:
    5.7
  • 作者:
    Kocher, Kristen;Bhattacharya, Surajit;Bramble, Matthew S.;Okitundu-Luwa, Daniel;Ngoyi, Dieudonne Mumba;Tshala-Katumbay, Desire;Vilain, Eric
  • 通讯作者:
    Vilain, Eric
Risk Factors for Ebola Exposure in Health Care Workers in Boende, Tshuapa Province, Democratic Republic of the Congo.
The gut microbiome in konzo.
  • DOI:
    10.1038/s41467-021-25694-1
  • 发表时间:
    2021-09-10
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Bramble MS;Vashist N;Ko A;Priya S;Musasa C;Mathieu A;Spencer A;Lupamba Kasendue M;Mamona Dilufwasayo P;Karume K;Nsibu J;Manya H;Uy MNA;Colwell B;Boivin M;Mayambu JPB;Okitundu D;Droit A;Mumba Ngoyi D;Blekhman R;Tshala-Katumbay D;Vilain E
  • 通讯作者:
    Vilain E
Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Bloodstream Infections in Peru and Associated Outcomes: VIRAPERU Study.
  • DOI:
    10.4269/ajtmh.22-0556
  • 发表时间:
    2023-11-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Krapp F;García C;Hinostroza N;Astocondor L;Rondon CR;Ingelbeen B;Alpaca-Salvador HA;Amaro C;Aguado Ventura C;Barco-Yaipén E;Bocangel Fernandez C;Briones A;Burgos A;Campana R;Castillo K;Castañeda-Sabogal A;Coaquira A;Concha-Velasco F;Cuadros EC;Chincha O;Diaz JC;Díaz Sipión R;Fernandez V;Hueda-Zavaleta M;López E;Valera-Krumdieck M;Vásquez R;Vidaurre Torres AM;Villegas-Chiroque M;Sarmiento Lopez F;Sullón Zavaleta PA;Sierra Chavez E;Paricahua Peralta E;Peralta Córdova T;Pino-Dueñas JE;Jacobs J
  • 通讯作者:
    Jacobs J
Knowledge, attitudes, and practices of seasonal influenza vaccination in postpartum women, Honduras.
  • DOI:
    10.1371/journal.pone.0246385
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Madewell ZJ;Chacón-Fuentes R;Jara J;Mejía-Santos H;Molina IB;Alvis-Estrada JP;Coello-Licona R;Montejo B
  • 通讯作者:
    Montejo B
共 125 条
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 25
前往

CRAIG R COHEN的其他基金

University of California Launching Future Leaders in Global Health Research Training Program
加州大学推出全球健康研究未来领导者培训计划
  • 批准号:
    10879589
    10879589
  • 财政年份:
    2023
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
在南非德班感染艾滋病毒高危女性中进行的 LACTIN-V(卷曲乳杆菌 CTV-05)的 2 期安慰剂对照随机试验
  • 批准号:
    10406532
    10406532
  • 财政年份:
    2021
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
University of California Global Health Institute Program for Fellows and Scholars
加州大学全球健康研究所研究员和学者计划
  • 批准号:
    10253430
    10253430
  • 财政年份:
    2021
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
在南非德班感染艾滋病毒高危女性中进行的 LACTIN-V(卷曲乳杆菌 CTV-05)的 2 期安慰剂对照随机试验
  • 批准号:
    10372975
    10372975
  • 财政年份:
    2019
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
在南非德班感染艾滋病毒高危女性中进行的 LACTIN-V(卷曲乳杆菌 CTV-05)的 2 期安慰剂对照随机试验
  • 批准号:
    10617632
    10617632
  • 财政年份:
    2019
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
在南非德班感染艾滋病毒高危女性中进行的 LACTIN-V(卷曲乳杆菌 CTV-05)的 2 期安慰剂对照随机试验
  • 批准号:
    10488446
    10488446
  • 财政年份:
    2019
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
Uwezo: Developing an Office of Sponsored Research in KEMRI with HIV Research Training
Uwezo:通过艾滋病毒研究培训在 KEMRI 中建立一个赞助研究办公室
  • 批准号:
    9277256
    9277256
  • 财政年份:
    2016
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
Agricultural intervention for food security and HIV healthoutcomes in Kenya
肯尼亚粮食安全和艾滋病毒健康结果的农业干预
  • 批准号:
    9064868
    9064868
  • 财政年份:
    2015
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
Agricultural intervention for food security and HIV healthoutcomes in Kenya
肯尼亚粮食安全和艾滋病毒健康结果的农业干预
  • 批准号:
    8922460
    8922460
  • 财政年份:
    2015
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
Preclinical Development of MucoCept
MucoCept 的临床前开发
  • 批准号:
    9121468
    9121468
  • 财政年份:
    2015
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:

相似国自然基金

数智背景下的团队人力资本层级结构类型、团队协作过程与团队效能结果之间关系的研究
  • 批准号:
    72372084
  • 批准年份:
    2023
  • 资助金额:
    40 万元
  • 项目类别:
    面上项目
双单亲遗传贝类线粒体与核氧化磷酸化基因动态协作调控机制
  • 批准号:
    32302965
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
降水变化下土壤动物协作效应对土壤有机质形成过程的影响
  • 批准号:
    42307409
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
反硝化厌氧甲烷氧化菌群信号交流协作机制与调控策略
  • 批准号:
    52300068
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
在线医疗团队协作模式与绩效提升策略研究
  • 批准号:
    72371111
  • 批准年份:
    2023
  • 资助金额:
    41 万元
  • 项目类别:
    面上项目

相似海外基金

2023 Sex Differences in Immunity Gordon Research Conference
2023 年免疫性别差异戈登研究会议
  • 批准号:
    10681988
    10681988
  • 财政年份:
    2023
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
  • 批准号:
    10758129
    10758129
  • 财政年份:
    2023
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
ShEEP Request for the purchase of a research- grade Cell Imaging Multi-mode Reader
ShEEP 请求购买研究级细胞成像多模式读取器
  • 批准号:
    10739194
    10739194
  • 财政年份:
    2023
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
Exploring, Predicting, and Intervening on Long-term Viral suppression Electronically (EPI-LoVE)
电子方式探索、预测和干预长期病毒抑制 (EPI-LoVE)
  • 批准号:
    10676683
    10676683
  • 财政年份:
    2023
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别:
Engaging Underrepresented Racial/Ethnic Minority Students in Aging Research
让少数族裔学生参与老龄化研究
  • 批准号:
    10627635
    10627635
  • 财政年份:
    2023
  • 资助金额:
    $ 16.46万
    $ 16.46万
  • 项目类别: